Cryo-Cell International Inc (CCEL)
7.15
-0.22
(-2.99%)
USD |
NYAM |
Nov 05, 16:00
7.15
0.00 (0.00%)
After-Hours: 19:00
Cryo-Cell International Enterprise Value: 68.02M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 68.02M |
| November 01, 2024 | 66.73M |
| October 31, 2024 | 67.78M |
| October 30, 2024 | 67.54M |
| October 29, 2024 | 55.52M |
| October 28, 2024 | 56.49M |
| October 25, 2024 | 57.38M |
| October 24, 2024 | 58.59M |
| October 23, 2024 | 59.39M |
| October 22, 2024 | 58.59M |
| October 21, 2024 | 58.75M |
| October 18, 2024 | 59.74M |
| October 17, 2024 | 58.51M |
| October 16, 2024 | 58.99M |
| October 15, 2024 | 55.70M |
| October 14, 2024 | 57.38M |
| October 11, 2024 | 59.07M |
| October 10, 2024 | 60.84M |
| October 09, 2024 | 60.92M |
| October 08, 2024 | 61.33M |
| October 07, 2024 | 59.39M |
| October 04, 2024 | 59.89M |
| October 03, 2024 | 59.80M |
| October 02, 2024 | 59.96M |
| October 01, 2024 | 58.99M |
| Date | Value |
|---|---|
| September 30, 2024 | 59.96M |
| September 27, 2024 | 60.84M |
| September 26, 2024 | 61.25M |
| September 25, 2024 | 60.28M |
| September 24, 2024 | 61.09M |
| September 23, 2024 | 58.67M |
| September 20, 2024 | 63.59M |
| September 19, 2024 | 58.34M |
| September 18, 2024 | 58.99M |
| September 17, 2024 | 58.43M |
| September 16, 2024 | 59.55M |
| September 13, 2024 | 59.88M |
| September 12, 2024 | 59.39M |
| September 11, 2024 | 61.33M |
| September 10, 2024 | 58.83M |
| September 09, 2024 | 61.17M |
| September 06, 2024 | 63.03M |
| September 05, 2024 | 60.41M |
| September 04, 2024 | 61.01M |
| September 03, 2024 | 62.13M |
| August 31, 2024 | 58.59M |
| August 30, 2024 | 61.20M |
| August 29, 2024 | 63.54M |
| August 28, 2024 | 63.62M |
| August 27, 2024 | 64.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.34M
Minimum
Mar 28 2023
115.67M
Maximum
Sep 02 2021
60.83M
Average
57.76M
Median
Sep 04 2020
Enterprise Value Benchmarks
| American Shared Hospital Services | 31.12M |
| Novo Integrated Sciences Inc | 4.018M |
| Astrana Health Inc | 2.392B |
| P3 Health Partners Inc | 316.56M |
| Biote Corp | 255.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.052M |
| Revenue (Quarterly) | 8.067M |
| Total Expenses (Quarterly) | 6.664M |
| EPS Diluted (Quarterly) | 0.13 |
| Gross Profit Margin (Quarterly) | 73.65% |
| Profit Margin (Quarterly) | 13.04% |
| Earnings Yield | -15.01% |
| Operating Earnings Yield | 6.11% |
| Normalized Earnings Yield | 2.620 |